Kathmere Capital Management’s Elevance Health ELV Stock Holding History

Kathmere Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$597K	Buy	1,543 +664	+76%	+$246K	0.03%	358
2026 Q1	$257K	Sell	879 -749	-46%	-$246K	0.02%	513
2025 Q4	$571K	Buy	1,628 +154	+10%	+$52K	0.04%	283
2025 Q3	$476K	Sell	1,474 -828	-36%	-$258K	0.03%	303
2025 Q2	$896K	Sell	2,302 -375	-14%	-$151K	0.07%	181
2025 Q1	$1.16M	Buy	2,677 +1,592	+147%	+$639K	0.1%	130
2024 Q4	$400K	Buy	+1,085	New	+$454K	0.04%	270
2024 Q3	–	Sell	-388	Closed	-$210K	–	385
2024 Q2	$210K	Buy	+388	New	+$205K	0.02%	314
2022 Q3	–	Sell	-626	Closed	-$302K	–	175
2022 Q2	$302K	Buy	626 +26	+4%	+$12.9K	0.06%	121
2022 Q1	$295K	Buy	600 +136	+29%	+$62.2K	0.05%	129
2021 Q4	$215K	Buy	+464	New	+$195K	0.04%	130
2021 Q1	–	Sell	-462	Closed	-$148K	–	221
2020 Q4	$148K	Buy	462 +14	+3%	+$4.3K	0.03%	155
2020 Q3	$120K	Sell	448 -313	-41%	-$84.2K	0.03%	152
2020 Q2	$200K	Buy	+761	New	+$203K	0.06%	111

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kathmere Capital Management's ELV Position: Q2 2026 in Review

Kathmere Capital Management increased its Elevance Health (ELV) stake by 76% in Q2 2026, buying an estimated $246K and bringing the position to 1,543 shares worth $597K. The position accounts for 0.03% of the portfolio, ranked #358.

Kathmere Capital Management first reported a position in ELV in Q2 2020 and has held it in 14 quarters since. The position peaked at $1.16M in Q1 2025. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Kathmere Capital Management held 1,543 shares of Elevance Health worth $597K as of Q2 2026.
Kathmere Capital Management bought 664 Elevance Health shares in Q2 2026, an estimated $246K.
Elevance Health made up 0.03% of Kathmere Capital Management's portfolio in Q2 2026, its #358 holding.
Kathmere Capital Management first reported a position in Elevance Health in Q2 2020 and has held it in 14 quarters since.
Kathmere Capital Management's Elevance Health position peaked at $1.16M in Q1 2025.
1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.